Founder of CNBX Pharmaceuticals, Inc. and Cannabics, Inc., Eyal Barad currently occupies the position of Chief Executive Officer & Director at CNBX Pharmaceuticals, Inc. and Chief Executive Officer & Director at G.R.I.N. Ultra Ltd.

He previously was Chief Executive Officer of Cannabics, Inc. and Vice President for The Israel-canada Chamber of Commerce & Industry.

He received an undergraduate degree from The Hebrew University of Jerusalem and an MBA from the University of Haifa.